LobbyingHarmony Biosciences Management lobbying by quarter
Harmony Biosciences Management's latest lobbying report covers Q4 2025, at $40K. The four quarters Q4 2025–Q3 2026 total $40K. Its first report covers Q3 2025; the issues it reports most are Health Issues.
Harmony Biosciences Management
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $40K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$80K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Schaerr Jaffe | $80K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/20for Q4 2025 | Schaerr Jaffe | $40K |
| 25/10/17for Q3 2025 | Schaerr Jaffe | $40K |
| 25/07/25for Q3 2025 | Schaerr Jaffe | Under $5,000 |